Synthetic Biology for Natural Product Development

Synthetic biology applies engineering principles to the design, construction and optimisation of biological systems for the sustainable production of natural compounds. By refactoring biosynthetic pathways, assembling standardised genetic parts and employing advanced genome‐editing tools, researchers can reprogramme microbial and cell‐free platforms to synthesise complex molecules that were once accessible only through extraction from plants, fungi or marine organisms. Central to this endeavour is the integration of computational modelling, high‐throughput screening and modular DNA assembly techniques, which together enable rapid pathway iteration and yield improvement. Key strategies include chassis engineering of bacteria or yeast, heterologous expression of entire biosynthetic gene clusters, dynamic regulation of metabolic flux and deployment of cell‐free enzymatic cascades. These approaches underpin significant advances in the manufacture of pharmaceuticals, nutraceuticals, agrochemicals and fine chemicals, offering greener alternatives to conventional synthetic chemistry. Beyond enhancing yields and reducing environmental impact, synthetic biology fosters access to rare or cryptic natural products, facilitates structural diversification through enzyme engineering and paves the way for on‐demand biomanufacturing. The field’s global significance lies in its capacity to secure supply chains for essential medicines, drive cost‐effective production in resource‐limited settings and accelerate the discovery of novel bioactive compounds with therapeutic or industrial value.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Synthetic Biology for Natural Product Development publication trend

The graph below shows the total number of articles in synthetic biology for natural product development across all publications each year (not limited to Nature Index journals).

Technical terms

Heterologous expression: Introduction and expression of a gene or pathway from one organism into a different host to enable new biosynthetic capabilities.

Biosynthetic gene cluster (BGC): A contiguous set of genes encoding enzymes and regulatory elements required for the production of a specific natural product.

Cell-free system: An in vitro reaction environment containing purified enzymes or cell extracts used to catalyse metabolic pathways without living cells.

Modular DNA assembly: A set of standardised methods for combining genetic parts—such as promoters, coding sequences and terminators—into larger constructs.

Metagenome mining: Exploration of environmental DNA sequence data to identify novel enzymes or pathways that can be harnessed for biocatalysis or biosynthesis.

Chassis engineering: Genetic and metabolic optimisation of a host organism to enhance performance, stability and compatibility with introduced pathways.

References

1. Applications of synthetic biology in medical and pharmaceutical fields. Signal Transduction and Targeted Therapy (2023).
2. Multienzymatic Cascades and Nanomaterial Scaffolding—A Potential Way Forward for the Efficient Biosynthesis of Novel Chemical Products. Advanced Materials (2023).
3. The Impact of Metagenomics on Biocatalysis. Angewandte Chemie International Edition (2024).